Hillhouse Capital is set to supply more than $830m for JD.com's pharmaceutical and medical services spinoff, which raised about $1bn last year.
JD Health, the medical product retailer spun off by China-based e-commerce group JD.com, agreed an equity investment with hedge fund manager Hillhouse Capital on Monday likely to be over $830m.
The funding will consist of series B shares, according to JD.com’s second quarter results announcement. Hillhouse took part in JD.com’s $65m series C round in 2012, and the company has a market capitalisation exceeding $100bn today.
JD Health sells and delivers a range of products including prescription medication, medical supplies,…
